Forward Pharma Raises $220M In Year's Largest Biotech IPO
Denmark-based multiple sclerosis treatment developer Forward Pharma A/S drew $220 million in its initial public offering after pricing at the midpoint of its range Wednesday, the firm said, making it the...To view the full article, register now.
Already a subscriber? Click here to view full article